within Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G01A_AntiinfectivesAndAntisepticsExclCombinationsWithCorticosteroids.G01AX06_Furazolidone;

model Furazolidone
  extends Pharmacolibrary.Drugs.ATC.G.G01AX06;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>G01AX06</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Furazolidone is a nitrofuran derivative with antibacterial and antiprotozoal properties, used historically for the treatment of bacterial and protozoal gastrointestinal infections such as giardiasis, cholera, and diarrhea due to Escherichia coli. Due to concerns over toxicity and mutagenicity, its use has been discontinued or severely restricted in many countries and it is not approved in the US or Europe for human use.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for adult humans based on limited historical reports in the absence of comprehensive published human PK data. Parameters are provided as approximate estimates only.</p><h4>References</h4><ol><li><p>Plakas, SM, et al., &amp; Stehly, GR (1994). Furazolidone disposition after intravascular and oral dosing in the channel catfish. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 24(11) 1095–1105. DOI:<a href=&quot;https://doi.org/10.3109/00498259409038669&quot;>10.3109/00498259409038669</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7701851/&quot;>https://pubmed.ncbi.nlm.nih.gov/7701851</a></p></li><li><p>White, AH (1989). Absorption, distribution, metabolism, and excretion of furazolidone. A review of the literature. <i>Scandinavian journal of gastroenterology. Supplement</i> 169 4–10. DOI:<a href=&quot;https://doi.org/10.3109/00365528909091325&quot;>10.3109/00365528909091325</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2694342/&quot;>https://pubmed.ncbi.nlm.nih.gov/2694342</a></p></li><li><p>Silva, KMMN, et al., &amp; Silva-Caldeira, PP (2019). Concomitant and controlled release of furazolidone and bismuth(III) incorporated in a cross-linked sodium alginate-carboxymethyl cellulose hydrogel. <i>International journal of biological macromolecules</i> 126 359–366. DOI:<a href=&quot;https://doi.org/10.1016/j.ijbiomac.2018.12.136&quot;>10.1016/j.ijbiomac.2018.12.136</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30572056/&quot;>https://pubmed.ncbi.nlm.nih.gov/30572056</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Furazolidone;
